Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 27 min 37 sec ago

Deciphera Pharmaceuticals Appoints Michael D. Taylor, Ph.D., as President and Chief Executive Officer

Mon, 04/07/2014 - 13:04
Company to Accelerate Kinase Inhibitor Clinical Candidates in Cancer Company to Open Corporate Offices in Boston Area LAWRENCE, Kan.--(Healthcare Sales & Marketing Network)--Deciphera Pharmaceuticals, a clinical stage biotechnology company developing...
Biopharmaceuticals, Personnel
Deciphera Pharmaceuticals

Meda and Valeant Terminates Joint Ventures

Mon, 04/07/2014 - 12:57
GÖTEBORG, Sweden--(Healthcare Sales & Marketing Network)--Meda (STO:MEDAA) has reached an agreement with Valeant to terminate the companies’ joint ventures in Canada, Mexico and Australia in the second quarter of 2014. In all three countries own Meda ...
Meda AB, Valeant, Flupirtine, Onsolis, Sublinox

Merck Serono Announces Initiation of Phase III START2 Study with Tecemotide in Stage III Non-Small Cell Lung Cancer

Mon, 04/07/2014 - 12:52
First patient dosed in tecemotide Phase III trial; study recruiting across 250 sites in over 20 countries Related Stories START2 builds upon the data from the START* trial and explores the potential of tecemotide in patients with Stage III NSCLC who ha...
Biopharmaceuticals, Oncology
Merck Serono, START2, L-BLP25, NSCLC

Genzyme to Resubmit Lemtrada(TM) Application for FDA Review

Mon, 04/07/2014 - 12:42
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Genzyme, a Sanofi company (EURONEXT:SAN and NYSE:SNY), announced today that following constructive discussions with the U.S. Food and Drug Administration (FDA) the company plans to resubmit in the s...
Biopharmaceuticals, Neurology
Genzyme, Sanofi, Lemtrada, alemtuzumab, multiple sclerosis

Via Surgical Ltd. Receives FDA Clearance to Commercialize FasTouch(TM), the First Suture-Like Mesh Fixation System for Hernia Repair

Fri, 04/04/2014 - 19:37
AMIRIM, Israel, April 4, 2014 -- (Healthcare Sales & Marketing Network) -- Via Surgical Ltd., a leading developer of hernia mesh fixation technologies, today announced that it has received FDA 510(k) clearance to commercialize FasTouchTM. FasTouch fixatio...
Devices, Surgery, FDA
Via Surgical, FasTouch, hernia repair

Statement by the Board of Directors of Meda

Fri, 04/04/2014 - 15:52
GÖTEBORG, Sweden--(Healthcare Sales & Marketing Network)--This statement is made by the Board of Directors (the ”Board”) of Meda AB (publ) (”Meda”)(STO:MEDAA) pursuant to the Securities Markets Act and/or the Financial Instruments Trading act. The ...
Biopharmaceuticals, Mergers & Acquisitions
Meda AB, Mylan

Integra LifeSciences Announces Camino(R) Flex Ventricular Catheter Receives FDA Clearance for Use With MRI Scans

Fri, 04/04/2014 - 15:49
PLAINSBORO, N.J., April 4, 2014 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (IART) today announced that the Camino(R) Flex Ventricular Catheter has received clearance from the United States Food and Drug Administr...
Devices, Neurosurgery, FDA
Integra LifeSciences, Camino Flex, Ventricular Catheter, ICP monitor

Escalon(R) Medical Corp. Receives FDA 510(k) Clearance for the Sonomed Escalon VuPad(TM)

Fri, 04/04/2014 - 15:46
An innovation in ultrasound you can see and touch ARDMORE, Pa., April 4, 2014 -- (Healthcare Sales & Marketing Network) -- Escalon Medical Corp. (ESMC) today announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ne...
Devices, FDA
Escalon Medical, Sonomed Escalon VuPad, ultrasound, imaging

World's First and Only Upgradeable Spinal Cord Stimulation System Receives FDA Approval

Fri, 04/04/2014 - 15:40
Protégé upgradeable neurostimulator from St. Jude Medical is the world’s smallest, longest-lasting rechargeable device to treat chronic pain SCS system is designed to be non-invasively upgraded to leverage evolving technologies as they are...
Devices, Neurology, FDA
St. Jude Medical, Protégé IPG, neuromodulation, spinal cord stimulation

GTx Announces Departure of CEO

Fri, 04/04/2014 - 15:36
Dr. Mitchell Steiner steps down as CEO and Vice Chairman of the Board Marc Hanover, GTx’s President and COO, named interim CEO MEMPHIS, Tenn.--(Healthcare Sales & Marketing Network)--GTx, Inc. (GTXI) today announced that Mitchell S. Steiner, its vice...
Biopharmaceuticals, Oncology, Personnel
GTx, enobosarm

EDWARDS INTUITY Elite Valve System Receives CE Mark

Fri, 04/04/2014 - 15:29
Next-Generation Technology Built on Trusted, Proven Platform Designed for Enhanced Patient Benefits IRVINE, CA--(Healthcare Sales & Marketing Network) - Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and he...
Devices, Cardiology, Regulatory
Edwards Lifesciences, INTUITY Elite valve, aortic valve, heart valve

Omnis Health Introduces EmbracePro(TM) – Professional Blood Glucose Meter

Thu, 04/03/2014 - 16:05
NASHVILLE, Tenn.--(Healthcare Sales & Marketing Network)--Omnis Health, a leader in diabetes monitoring systems, today announced the launch of the new EmbracePro™, a blood glucose meter for medical professionals. Approved for multi-patient use, EmbracePro ...
Devices, Monitoring, Endocrinology, Product Launch
Omnis Health, EmbracePro, Blood Glucose, glucose monitor

Holaira Closes $42 Million Venture Financing Round

Thu, 04/03/2014 - 16:03
Investment Led by Vertex Venture Holdings to Support Randomized Clinical Trial MINNEAPOLIS, MN--(Healthcare Sales & Marketing Network) - Holaira, Inc., a developer of medical devices to treat obstructive lung diseases, today announced the completion of ...
Devices, Venture Capital, Personnel
Holaira, chronic obstructive pulmonary disease, COPD

Eko Devices Launches Eko, a Groundbreaking Stethoscope Technology and Software Designed to Enhance Cardiac Care

Thu, 04/03/2014 - 15:58
The Digital Stethoscope Device Will Be Unveiled at DEMO Enterprise 2014; New Technology Enables Clinicians to Amplify, Record, and Analyze Heart Sounds SAN FRANCISCO, CA--(Healthcare Sales & Marketing Network) - Eko Devices -- -- a UC...
Devices, Cardiology, Product Launch
Eko Devices, Eko, stethoscope

Astellas Announces European Regulatory Submission For XTANDI(R) (enzalutamide) Capsules For Chemotherapy-Naive Metastatic Prostate Cancer

Thu, 04/03/2014 - 15:53
TOKYO and SAN FRANCISCO, April 3, 2014 -- (Healthcare Sales & Marketing Network) -- Astellas Pharma Inc. (TSE:4503) and Medivation Inc. (MDVN) today announced the submission of a variation to amend the European Marketing Authorization Application for XTAN...
Biopharmaceuticals, Oncology, Regulatory
Astellas Pharma, XTANDI, enzalutamide, prostate cancer

EMBL Ventures Invests £2M ($3.3M) in a Second Close of Crescendo Biologics' Series A Financing

Thu, 04/03/2014 - 15:50
£19.5M raised to drive development of best-in-class fully human VH antibody fragment therapeutics CAMBRIDGE, England, April 3, 2014 -- (Healthcare Sales & Marketing Network) --Crescendo Biologics Limited (Crescendo) today announces it has raised ...
Biopharmaceuticals, Oncology, Venture Capital
Crescendo Biologics, VH fragment

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong